Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSONG.L Regulatory News (SONG)

  • There is currently no data for SONG

Increased Debt Facility

15 Apr 2020 07:00

RNS Number : 6390J
Hipgnosis Songs Fund Limited
15 April 2020
 

15 April 2020

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Increased Debt Facility

The Board of Hipgnosis Songs Fund Limited and its Investment Adviser, The Family (Music) Limited, are pleased to announce that the Company has entered into an agreement with a syndicated group of lenders, with JPMorgan Chase Bank as Lead Arranger, to increase its Revolving Credit Facility from £100 million to £150 million. The Company may request an increase in the Revolving Credit Facility commitment by a further £50 million subject to certain conditions. The amended Revolving Credit Facility will provide Hipgnosis with greater flexibility to fund investments and provide additional working capital. In accordance with Hipgnosis' investment policy, any borrowings by the Company will not exceed 20 per cent. of the value of the assets of the Company less its liabilities.

In addition to the increase of the commitment of the Revolving Credit Facility, the maturity date has been extended from 29 August 2022 to 2 April 2025. Other key terms of the Revolving Credit Facility remain in effect.

For further information, please contact:

The Family (Music) Limited

Merck Mercuriadis

 

Tel: +44 (0)1481 742742

N+1 Singer - Joint Corporate Broker

James Maxwell / James Moat (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales)

 

Tel: +44 (0)20 7496 3000

J.P. Morgan Cazenove - Joint Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

James Bouverat (Sales)

 

Tel: +44 (0)20 7742 4000

The Outside Organisation

Alan Edwards / Nick Caley

Tel: +44 (0)7711 081 843

 

NOTES TO EDITORS

About Hipgnosis Songs Fund Limited

(www.hipgnosissongs.com)

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. The Company has raised a total of over £625 million (gross equity capital) through its Initial Public Offering on 11 July 2018, and subsequent issues in April 2019, August 2019 and October 2019. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premium segment of the Main Market.

About The Family (Music) Limited

The Company's Investment Adviser is The Family (Music) Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of The Family (Music) Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, Nick Jarjour, David Stewart, Bill Leibowitz, Ian Montone, and Jason Flom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRSFFFMLESSEFL
Date   Source Headline
13th Jul 20237:00 amRNSAnnual Financial Report
10th Jul 20237:00 amRNSDirectorate Change and Notice of Results
23rd Jun 202312:02 pmRNSDividend Declaration
16th May 20237:00 amRNSCorrection of Director/PDMR Shareholding
15th May 20234:32 pmRNSDirector/PDMR Shareholding
3rd May 20237:00 amRNSDirectorate Change
16th Mar 20237:00 amRNSDividend Declaration
10th Mar 20235:00 pmRNSDirector/PDMR Shareholding
10th Mar 20234:50 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSTotal Voting Rights
23rd Dec 202211:53 amRNSPublication of Factsheet
13th Dec 20224:03 pmRNSHoldings in Company-Notification of Major Holdings
8th Dec 20227:01 amRNSDividend Declaration
8th Dec 20227:00 amRNSHalf-year Report
5th Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 202210:05 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSNotice: Half Year Results and Capital Markets Day
24th Nov 20226:06 pmRNSHolding(s) in Company
18th Nov 20227:00 amRNSTransaction in Own Shares
14th Nov 20223:29 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSKepler Trust Intelligence: New Research
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20227:01 amRNSTransaction in Own Shares
1st Nov 20227:00 amRNSTotal Voting Rights
31st Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20223:35 pmRNSHolding(s) in Company
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20223:16 pmRNSReplacement Transaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSShare Repurchase Programme
10th Oct 20224:41 pmRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSHipgnosis Songs Fund announces interest rate hedge
3rd Oct 20227:00 amRNSHipgnosis Songs Fund announces debt refinancing
21st Sep 20222:59 pmRNSResult of Fourth AGM
21st Sep 20227:00 amRNSDividend Declaration
12th Sep 20224:42 pmRNSRevised Voting by Proxy Deadline
2nd Sep 20224:44 pmRNSHolding(s) in Company
8th Aug 20224:12 pmRNSHolding(s) in Company
3rd Aug 20227:00 amRNSNotice of Annual General Meeting
14th Jul 20227:01 amRNSNew Administration Agreements - Sacem & peermusic
14th Jul 20227:00 amRNSAnnual Financial Report
13th Jul 20227:00 amRNSDirector/PDMR Shareholding
4th Jul 20227:00 amRNSImpact of Copyright Royalty Board III Decision
12th May 20227:00 amRNSDividend Declaration
13th Apr 202212:05 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSKepler Trust Intelligence: New Research
8th Feb 20227:00 amRNSDividend Declaration
16th Dec 20217:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.